Protalix Biotherapeutics Inc (PLX)
Operating Cash Flow Growth
552.07%
TTM · Period ending:
PLX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported552.07%period ending
Latest reported552.07%period ending
PLX TTM Cash from Operations YoY % (66.67% → 552.07%)
Year-over-year change
High-resolution chart · PNG
PLX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 205.1584% | |
| 94.3282% | |
| 96.2285% | |
| 83.5921% | |
| 71.0978% | |
| 26.9308% | |
| -54.7403% | |
| -142.6031% | |
| -2,304.3133% | |
| -119.882% | |
| -49.1803% | |
| -55.5556% | |
| 66.6667% |